Skip to content

LanzaTech Global, Inc. LNZA Equity method investments (Note 11)

Equity method investments (Note 11) at other companies

Chart Industries logo
Chart IndustriesGTLS
OPA
OPAL Fuels Inc.OPAL
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
Linde logo
LindeLIN

Other financials

Income statement

See full
Revenue$12.0M+26.8%
Operating income-$9.8M+68.4%
Net income-$14.7M+23.7%
EPS (diluted)-$1.77+81.9%

Balance sheet

See full
Cash & equivalents$19.9M+23.9%
Total debt$16.3M-46.1%
Total equity$48.1M+4,194%
Total assets$105.2M-16.4%

Cash flow

See full
Operating cash flow-$9.3M+56.1%
CapEx$55.0K-92.3%
Free cash flow-$9.3M+57.3%

Valuation

See full
Market cap$75.63M-75.8%
Enterprise value$72.09M-75.1%
P/S1.3×-6.4×

Profitability

See full
Operating margin-99.2%-36.2pp
Net margin-76.1%-31.8pp
FCF margin-91.8%-29.8pp

Returns & leverage

See full
Return on equity-215.3%
Debt / equity0.3×
Current ratio-0.2×

Where this comes from

Reported directly by LanzaTech Global, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: LanzaTech Global, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about LanzaTech Global, Inc.'s equity method investments (note 11).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LanzaTech Global, Inc.'s equity method investments (note 11)?
LanzaTech Global, Inc. (LNZA) reported equity method investments (note 11) of $11.32M in Q1 2026.
What is the long-term trend for LanzaTech Global, Inc.'s equity method investments (note 11)?
Over 3 years (2022 to 2025), LanzaTech Global, Inc.'s equity method investments (note 11) has grown at a 7.9% compound annual growth rate (CAGR), from $10.56M to $13.27M.